Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data.

Anna Buda-Nowak,Łukasz Kwinta,Paweł Potocki,Anna Michałowska-Kaczmarczyk,Agnieszka Słowik,Kamil Konopka,Joanna Streb,Maciej Koniewski,Piotr J Wysocki

Journal of clinical medicine（2023）

引用 2|浏览9

暂无评分

摘要

Metronomic chemo-endocrine therapy with FulVEC regimen represents an interesting option and compares favorably with other approaches in patients' refractory to endocrine treatments. A phase II randomized trial is warranted.

查看译文

关键词

FulVEC,breast cancer,chemo-endocrine therapy,metronomic chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要